Publication | Closed Access

Lamivudine Compared With Newer Antivirals for Prophylaxis of Hepatitis B Core Antibody Positive Livers: A Cost-Effectiveness Analysis

VaccinationNewer AntiviralsCost-effectiveness AnalysisHepatologyViral HepatitisLamivudine ComparedImmunologyHepatitis BHepatitisAntiviral Drug DevelopmentComplications Of CirrhosisAntiviral TherapyAntiviral DrugMedicine